(Q45088976)

9 December 2017

title

Ciprofloxacin-induced renal insufficiency in cystic fibrosis (English)

1 reference

9 December 2017

0 references

Brady S Moffett

1

1 reference

9 December 2017

Beryl J Rosenstein

series ordinal

2

1 reference

9 December 2017

Peter J Mogayzel

series ordinal

3

1 reference

9 December 2017

publication date

1 September 2003

1 reference

Journal of Cystic Fibrosis

9 December 2017

published in

1 reference

9 December 2017

volume

2

1 reference

9 December 2017

issue

3

1 reference

9 December 2017

page(s)

152-154

1 reference

Fluoroquinolone-induced renal failure

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Quinolone toxicity: methods of assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin: an overview of adverse experiences

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Clinical use of fluoroquinolones in children

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin in neonates and its possible adverse effect on the teeth

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin-induced acute interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin safety in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Antibiotic-induced recurring interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

Typhoid fever, ciprofloxacin, and renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900059-6

7 January 2021

10.1016/S1569-1993(03)00059-6

Identifiers

DOI

1 reference

9 December 2017

1 reference